BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15218348)

  • 21. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 23. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma.
    Fujii T; Zen Y; Nakanuma Y
    J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcomatous cholangiocarcinoma.
    Gupta K; Powari M; Dey P
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract]   [Full Text] [Related]  

  • 28. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
    Harada K; Terada T; Nakanuma Y; Furukawa Y; Kurumaya H
    Am J Gastroenterol; 1993 Nov; 88(11):1968-9. PubMed ID: 8237956
    [No Abstract]   [Full Text] [Related]  

  • 30. The separate-lesion type combined hepatocellular carcinoma and cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(45):806-9. PubMed ID: 12063995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.
    De Vito C; Sarker D; Ross P; Heaton N; Quaglia A
    Virchows Arch; 2017 Nov; 471(5):619-629. PubMed ID: 28707055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case 6: Combined hepatocellular and cholangiocarcinoma].
    Bedossa P
    Ann Pathol; 2007 Apr; 27(2):112-4. PubMed ID: 17909467
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined hepatocellular-cholangiocarcinoma presented with massive pulmonary embolism.
    Koskinas J; Betrosian A; Kafiri G; Tsolakidis G; Garaziotou V; Hadziyannis S
    Hepatogastroenterology; 2000; 47(34):1125-8. PubMed ID: 11020895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report.
    Soeda J; Yazaki M; Nakata T; Miwa S; Ikeda S; Hosoda W; Iijima M; Kobayashi K; Saheki T; Kojiro M; Miyagawa S
    J Clin Gastroenterol; 2008 Aug; 42(7):855-60. PubMed ID: 18385606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of double liver cancer: hepatocellular carcinoma and combined hepatocellular and mucinous cholangiocarcinoma].
    Yamashita N; Nishiura S; Tanimoto H; Yamamoto H; Nomura H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Sep; 110(9):1663-72. PubMed ID: 24005108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R; Malhotra V; Kumar N; Sarin SK
    Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.